This compound is a deuterium-labeled, calcium salt form of a synthetic pyrrole derivative. It is primarily used as an active pharmaceutical ingredient in pharmaceutical manufacturing and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 222412-82-0
Atorvastatin IMpurity F
research compound
Ipratropium bromide
pharmaceutical raw material
Bromocriptine mesylate
pharmaceutical raw material
Val-Cit-PAB-Exatecan
pharmaceutical raw material
1-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutane-1-carboxylic acid
pharmaceutical raw material
Atorvastatin calcium trihydrate
pharmaceutical raw material
Ent-Atorvastatin
pharmaceutical raw material
7-{4-[anilino(oxo)methyl]-2-(4-fluorophenyl)-3-phenyl-5-propan-2-yl-1-pyrrolyl}-3,5-dihydroxyheptanoic acid
pharmaceutical raw material
calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-(2,3,4,5,6-pentadeuteriophenyl)-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate
DYJKAHNDTTZSNX-ADFDHUHVSA-M
[2H]C1=C(C(=C(C(=C1[2H])[2H])C2=C(N(C(=C2C(=O)NC3=CC=CC=C3)C(C)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)C4=CC=C(C=C4)F)[2H])[2H].[Ca+2]